GSK licenses stable cell line technology to Orchard – FirstWord Pharma
GSK licenses stable cell line technology to Orchard - FirstWord Pharma
Frost & Sullivan IDs Five New Technologies to Power Research Across...
Frost & Sullivan IDs Five New Technologies to Power Research Across Preclinical Disease Models
Tonix Pharmaceuticals Holding Corp. Closes $10.5 Million Common Stock Registered Direct...
Tonix Pharmaceuticals Holding Corp. Closes $10.5 Million Common Stock Registered Direct Offering Nasdaq:TNXP
RIBOMIC Announces Dosing of First Subject in RBM-007 Phase 1 Clinical...
RIBOMIC Announces Dosing of First Subject in RBM-007 Phase 1 Clinical Trial for Achondroplasia
Can-Fite Completes Phase II COVID-19 Protocol Based on FDA Guidance, Plans...
Can-Fite Completes Phase II COVID-19 Protocol Based on FDA Guidance, Plans to File IND Shortly
